Pharma News Only (pfe,mrk,wla, sgp, ahp, bmy, lly) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Pharma News Only (pfe,mrk,wla, sgp, ahp, bmy, lly)

PFE 24.31

0.0%

Oct 30 3:59 PM EDT

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: vestor who wrote (1690)	7/26/2001 9:54:46 PM
From: darbyred	Read Replies (1) of 1722

RDY has 6 months exclusive to market the 40 mg. I have some PFE which I "inherited" when it acquired Warner Lambert. It has been relatively inactive as far as any price spike since the merger was ratified. I share your enthusiasm for PFE. It appears to have a great pipeline that should positively affect its price per share. I am bothered when PFE is recommended as a "defensive investment." PFE has every opportunity to have 15-25% annual growth for each of the next several years.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next